跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 32,221 条关于
“IGF-I”
全部
32,221
临床试验
24,705
药物
975
机构
111
资讯
6,430
去年
Oral Paltusotine Demonstrates Efficacy in Phase 3 Acromegaly Trial, Offering Alternative to Injectable Treatments
上个月
Khartis Therapeutics Emerges from Stealth with $95 Million to Advance First Oral, Selective IGF-1R Inhibitor for Thyroid Eye Disease
7个月前
Oxford Completes Phase 0 Trial of IGF Antibody Xentuzumab in Prostate Cancer Patients
3个月前
Marea Therapeutics Presents Phase 1 Data for MAR002, a First-in-Class GHR Antibody, Showing Up to 64% IGF-1 Suppression in Acromegaly at ENDO 2026
去年
Biocytogen and Nanjing Chia Tai Tianqing Receive IND Approval for Second-Generation Anti-IGF-1R Antibody NTB003 in Thyroid Eye Disease
9个月前
Minghui Pharmaceutical Receives FDA Clearance for Phase III Trials of Novel Thyroid Eye Disease Treatment
4年前
Sling Therapeutics Initiates Enrollment in Phase 2b LIDS Clinical Trial for Thyroid Eye Disease
去年
Long-Term Obesity Accelerates Biological Aging in Young Adults, Study Finds
4年前
Sling Therapeutics Launches with $35M Series A Financing to Develop Oral Small Molecule for Thyroid Eye Disease
5个月前
Lirum Therapeutics' LX-101 Shows Promising Preclinical Activity in Ewing Sarcoma, Advances to RAPID Platform Trial
第 1 页,共 643 页
上一页
下一页